Paid Clinical Trials Colorado
Discover 1,648 paid clinical trials in Colorado. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction
Sponsor:
Axogen Corporation
Location:
Code:
NCT01526681
Conditions
Peripheral Nerve Injuries
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Processed Human Nerve Graft
Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.
Autogenous Nerve Graft
Nerve Tube Conduit
Autologous Breast Reconstruction with Neurotization
Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05156281
Conditions
Relapsing Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Remibrutinib
Teriflunomide
IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT04557462
Conditions
Primary IgA Nephropathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
LNP023
BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Sponsor:
BicycleTx Limited
Location:
Code:
NCT04561362
Conditions
Urinary Bladder Neoplasm
Triple Negative Breast Neoplasms
Hormone Receptor Positive, HER2-negative Neoplasms
Hormone Receptor Positive, HER2-low Neoplasms
Breast Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BT8009
Pembrolizumab
Nexel Total ElbowClinical Outcomes Study of the Nexel Total Elbow
Sponsor:
Zimmer Biomet
Location:
Code:
NCT02469662
Conditions
Elbow Joint Destruction
Post-traumatic Lesions
Ankylosed Joints
Advanced Rheumatoid Arthritis
Joint Instability or Loss of Motion
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nexel Total Elbow
Observational StudyLGMD R1 Natural History Study
Sponsor:
Virginia Commonwealth University
Location:
Code:
NCT05618080
Conditions
Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
Limb Girdle Muscular Dystrophy
Limb Girdle Muscular Dystrophy Type R1
LGMD2A
Eligibility Criteria
Sex: All
Age: 12 - 50
Healthy Volunteers: Not accepted
CX-4945Dose-escalation Study of Oral CX-4945
Sponsor:
Cylene Pharmaceuticals
Location:
Code:
NCT00891280
Conditions
Advanced Solid Tumors
Breast Cancer
Inflammatory Breast Cancer
Castleman's Disease
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CX-4945 oral formulation
BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
Sponsor:
Biogen
Location:
Code:
NCT05798520
Conditions
Relapsing Forms of Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
BIIB091
DRF
Placebo
NTLA-2002HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)
Sponsor:
Intellia Therapeutics
Location:
Code:
NCT06634420
Conditions
Hereditary Angioedema
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
NTLA-2002
Normal Saline IV Administration